Healthcare -
Biotechnology - NASDAQ - US
$ 32.65
0.276 %
$ 3.64 B
Market Cap
-34.73
P/E
VKTX - RESEARCH & DEVELOPMENT
Research & Development VKTX - Viking Therapeutics, Inc.
63.8 M
LAST VALUE
19.10%
2 YEAR CAGR
27.36%
5 YEAR CAGR
136.59%
10 YEAR CAGR